Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	237.94	231.4	249.55	219.15	126.35
Short-Term Investments	-	1,176	1,167	384.44	1,130	490.29
Trading Asset Securities	-	-	5.57	49.6	-	-
Cash & Short-Term Investments	2,006	1,413	1,404	683.59	1,349	616.64
Cash Growth	-8.74%	0.70%	105.34%	-49.34%	118.83%	55.25%
Accounts Receivable	-	4,384	4,043	3,852	3,928	4,638
Other Receivables	-	120.06	134.02	57.8	119.38	170.47
Receivables	-	4,504	4,178	3,910	4,048	4,810
Inventory	-	1,257	1,184	1,031	1,239	989.27
Prepaid Expenses	-	24.7	27.76	24.21	31.9	14.32
Other Current Assets	-	1,066	1,315	1,325	1,100	1,222
Total Current Assets	-	8,265	8,109	6,974	7,769	7,652
Property, Plant & Equipment	-	4,177	3,694	3,729	2,948	2,278
Long-Term Investments	-	310.67	80.2	568.59	36.75	620.13
Goodwill	-	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	-	2.3	1.07	2.29	3.83	5.79
Long-Term Deferred Tax Assets	-	-	-	33.33	-	-
Other Long-Term Assets	-	176.06	154.99	184.42	252.93	134.35
Total Assets	-	13,008	12,116	11,569	11,087	10,768
Accounts Payable	-	714.18	609.65	863.9	926.06	742.25
Accrued Expenses	-	96.8	64.46	55.09	47.86	50.93
Short-Term Debt	-	232.16	324.17	460.14	607.03	650.38
Current Portion of Long-Term Debt	-	279.13	197.98	113.63	210.32	211.11
Current Portion of Leases	-	44.1	27.55	11.14	9.42	13.18
Current Income Taxes Payable	-	37.74	18.66	26.56	66.49	86.01
Current Unearned Revenue	-	45.7	69.24	34.7	90.08	157.91
Other Current Liabilities	-	267.36	262.36	367.44	373.6	124.59
Total Current Liabilities	-	1,717	1,574	1,933	2,331	2,036
Long-Term Debt	-	198.46	355.92	406.9	232.22	326.04
Long-Term Leases	-	127.19	92.79	27.17	34.92	18.29
Long-Term Unearned Revenue	-	0.47	0.61	0.74	0.87	1.01
Pension & Post-Retirement Benefits	-	43.64	26.74	26.89	10.74	24.98
Long-Term Deferred Tax Liabilities	-	3	35.93	-	13.23	82.09
Total Liabilities	-	2,090	2,086	2,394	2,623	2,489
Common Stock	-	105.37	104.69	104.15	103.68	103.15
Additional Paid-In Capital	-	404.24	331.64	269.94	212.77	147.57
Retained Earnings	-	10,120	9,324	8,603	7,941	7,826
Comprehensive Income & Other	-	-126.06	-88.46	-138.53	-70.73	5.38
Total Common Equity	11,323	10,504	9,672	8,839	8,187	8,083
Minority Interest	-	414.71	357.9	335.27	277.6	196.56
Shareholders' Equity	11,682	10,918	10,030	9,174	8,465	8,279
Total Liabilities & Equity	-	13,008	12,116	11,569	11,087	10,768
Total Debt	524.91	881.04	998.4	1,019	1,094	1,219
Net Cash (Debt)	1,481	532.41	405.27	-335.39	255.5	-602.36
Net Cash Growth	17.88%	31.37%	-	-	-	-
Net Cash Per Share	13.84	5.02	3.82	-3.18	2.43	-5.71
Filing Date Shares Outstanding	105.75	105.37	104.69	104.15	103.68	103.36
Total Common Shares Outstanding	105.75	105.37	104.69	104.15	103.68	103.15
Working Capital	-	6,548	6,535	5,041	5,438	5,616
Book Value Per Share	107.21	99.68	92.39	84.87	78.97	78.36
Tangible Book Value	11,244	10,424	9,594	8,760	8,106	8,000
Tangible Book Value Per Share	106.46	98.93	91.64	84.10	78.19	77.56
Land	-	422.36	409.88	419.83	420.09	144.14
Buildings	-	1,360	1,369	1,437	1,059	1,055
Machinery	-	3,152	2,616	2,580	1,809	1,490
Construction In Progress	-	207.11	78.27	28.01	221.55	23.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.